Measles is spreading across the U.S. once again, with confirmed cases surpassing 300 for the first time since 2019, data from the Centers for Disease Control and Prevention shows. More: Measles is ...

The court directed the Centre to frame a no-fault compensation policy for people who suffered serious adverse events after Covid-19 vaccination, saying the State must support affected families under ...

Contrary to prevailing belief, an evolutionary analysis finds no evidence that most viruses with epidemic or pandemic potential that jumped from animals to people were shaped by selection in a lab or ...

That comes after the second phase of the Royal Commission of Inquiry released its findings on Tuesday.

Verdict comes after petitions filed by Rachana Gangu and others alleged that two women lost their lives in 2021 after taking the first dose of the Covishield vaccine ...

Moderna’s Omicron-adapted COVID-19 vaccines appear to reduce the risk of hospitalization and death in adults who are not pregnant or have a weakened immune system, according to a rapid review ...

The medical director of a health department on Michigan’s Thumb is bucking a decades-long trend in public health leadership. Not all are thrilled.

The Dutch health council is recommending that the age for the annual coronavirus vaccine is raised from 60 to 70 and older from the coming autumn. The number of infections, hospital admissions and ...

BioNTech shares listed in New York fell about a fifth in pre-trading after the firm made the announcement and posted a loss of €1.1 billion ($2.1b) for 2025. Married couple Ugur ...

Prasad's stint included several controversial vaccine decisions; the FDA is now searching for a new head for its vaccine division.

Updated mRNA-1273 vaccine was effective against severe COVID-19 outcomes in older and high-risk adults during the 2024-2025 season.

The founders of the biotech company that developed Comirnaty, the mRNA-based COVID-19 vaccine sold by BioNTech and Pfizer, will step down and form a new mRNA company.